Publications
- Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Faculty of Mathematics and Physics
- Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances2012 | Second Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Second Faculty of Medicine
- The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells2009 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells2009 | Second Faculty of Medicine
- The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells2008 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells2007 | Faculty of Science, Second Faculty of Medicine
- Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment2023 | Faculty of Science, Second Faculty of Medicine
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Faculty of Science, Second Faculty of Medicine
Loading network view...